RP09 Human primary granulosa cells did not replace Sertoli cells in enhancing Leydig cell response to gonadotropins
Year: 2026
Type: conference-abstract
Abstract: Background/Introduction FSH may be helpful to increase sperm production in infertile men, even if evidence supporting its use is weak. The use of FSH relies on its effect in Sertoli cells, which would produce growth factors enhancing Leydig cell response to LH and hCG. This study aims to test if Leydig cell response to LH and hCG may be improved by molecules from Sertoli cell origin. To this purpose, experiments were performed using murine Leydig tumor cell line 1 (mLTC-1) and FSH-treated ovarian primary granulosa cells (hGLC) obtained from women undergoing assisted reproduction, used as a substitute for human Sertoli cells. Methods hGLC were cultured in presence or in absence of 1 nM FSH. Medium was collected and used for conditioning of mLTC-1 cells. mLTC1 cells exposed to unconditioned cell medium served as a "reference". Then, cells were treated 6 h with increasing concentrations (10 fM-100 nM) of recombinant LH and hCG before the analysis of testosterone levels by homogenous time-resolved fluorescence assay. Results In "reference" condition, both gonadotropins induced a dose-dependent increase in testosterone production, with hCG showing greater potency than LH. Interestingly, conditioned medium from hGLC reduced responsiveness of mLTC-1 cells to both hormones. This inhibitory effect was even more pronounced when the conditioned medium was obtained from FSH-treated hGLC. Conclusion Results suggest that ovarian cells produced paracrine factors reducing the response to gonadotropins of closest LHCGR-expressing cells. Therefore, hGLC cannot replace the functions of Sertoli cells, suggesting the existence of sex-specific endocrine factors regulating gonadal cell metabolism.
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,292
OpenAlex ID: W7204458243
